• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Reviva Pharmaceuticals Hldg Inc (NQ: RVPH )

    0.9692 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 118
    Open 0.9692
    Bid (Size) 0.9686 (2)
    Ask (Size) 0.9687 (1)
    Prev. Close 0.9692
    Today's Range 0.9692 - 0.9692
    52wk Range 0.6000 - 6.800
    Shares Outstanding 22,650,266
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    RVPH Stock Earnings: Reviva Pharmaceuticals Beats EPS for Q2 2024
    RVPH stock results show that Reviva Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation - RVPH
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Regulatory Compliance
    Exposures Legal Regulatory

    Performance

    YTD
    -81.75%
    -81.75%
    1 Month
    -22.46%
    -22.46%
    3 Month
    -29.77%
    -29.77%
    6 Month
    -77.72%
    -77.72%
    1 Year
    -76.01%
    -76.01%

    More News

    Read More
    ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation - RVPH
    Via TheNewswire.com
    Topics Regulatory Compliance
    Exposures Legal Regulatory
    RVPH Stock Earnings: Reviva Pharmaceuticals Beats EPS for Q1 2024
    Via InvestorPlace
    ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation – RVPH
    From The Rosen Law Firm PA
    Via GlobeNewswire
    ROSEN, SKILLED INVESTOR COUNSEL, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation - RVPH
    Via NewMediaWire
    Topics Regulatory Compliance
    Exposures Legal Regulatory
    ROSEN, SKILLED INVESTOR COUNSEL, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation - RVPH
    Via TheNewswire.com
    Topics Regulatory Compliance
    Exposures Legal Regulatory
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    RVPH LOSS ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation – RVPH
    From The Rosen Law Firm, P.A.
    Via Business Wire
    REVIVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Reviva Pharmaceuticals Holdings, Inc. on Behalf of Reviva Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    RVPH Stock Earnings: Reviva Pharmaceuticals Misses EPS for Q4 2023
    Via InvestorPlace
    Brain Disease Cures: 3 Neuroscience Stocks Targeting Revolutionary Breakthroughs
    Via InvestorPlace
    Reviva to Present at Webull LIVE! Healthcare Webinar on January 17
    Via ACCESSWIRE
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Life Science Investor Forum: Presentations Now Available for Online Viewing
    From Virtual Investor Conferences
    Via GlobeNewswire
    Life Science Investor Forum Agenda Announced for December 14th, 2023
    From Virtual Investor Conferences
    Via GlobeNewswire
    Reviva to Participate in the Zacks Small-Cap Research Life Sciences Investor Forum
    From Virtual Investor Conferences
    Via GlobeNewswire
    Analyst Assessment On Reviva Pharmaceuticals' Positive Schizophrenia Trial Data - Sees More Than 200% Upside In Stock
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Could This Be A Breakthrough in Mental Health? Reviva's Schizophrenia Drug Shows Promising Results In Key Trial
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Sharps Technology, Reviva Pharmaceuticals, and American Resources Corp. Interviews to Air on the RedChip Money Report(R) on Bloomberg TV
    Via ACCESSWIRE
    Reviva Pharmaceuticals Holdings, Inc. and Aridis Pharmaceuticals, Inc. Interviews to Air on the RedChip Money Report(R) on Bloomberg TV
    Via ACCESSWIRE
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.